AngioDynamics ( Latham, NY) received CE Mark approval for the AngioVac venous drainage cannula and cardiopulmonary bypass circuit. The cannula is labeled for use during extracorporeal bypass for up to six hours, while the cardiopulmonary bypass circuit can be used in procedures requiring extracorporeal circulatory support for periods of up to six hours. The AngioVac venous drainage cannula and cardiopulmonary bypass circuit have already been FDA approved for use in the US.
The 22F coil-reinforced AngioVac venous drainage cannula is intended for use with off-the-shelf pump, filter, and reinfusion cannula made by other companies. The expandable distal tip of the cannula is actuated by a balloon, and is funnel shaped to facilitate venous drainage when the balloon is inflated. The novel funnel shape prevents intravascular material from clogging of the cannula and also allows for removal of extraneous material. Under the CE Mark approval the device can also be used for removal of fresh, soft thrombi or emboli. The device will hopefully go a long way in reducing the incidences of venous thromboembolic events that cause close to 500,000 deaths annually across the European Union.
Video report of AngioVac used to remove a delicious two foot clot at UCLA:
Product page: AngioVac Cannula and Circuit…
Press release: AngioDynamics Achieves CE Approval for AngioVac…
